Clinical Trial Update: Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating the effect on tumor perfusion of a gemcitabine and vismodegib chemotherapy given before surgery in resectable pancreatic adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vismodegib (Vismodegib)

Snippet

Sponsor: Jean-Luc Van Laethem | Conditions: Pancreatic Adenocarcinoma Resectable | EARLY_Phase 1 | Status: UNKNOWN